{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:45:52Z","timestamp":1794458752350,"version":"4.9.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>As the mortality of individuals suffering severe cutaneous injuries decreases, there is an increased need to improve the methods by which physicians treat the resultant scars. Fractional lasers, which create zones of ablation at variable depths, provide a powerful tool in the management of scar complications and deformities. After disruption of the normal skin barrier, these zones may be used to deliver drugs that may enhance scar resolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine the differences in clinical outcome for hypertrophic scars treated with laser-assisted corticosteroid delivery, as compared to laser-assisted 5-fluorouracil delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>In this prospective, double-blinded, single-subject study of 20 individuals with hypertrophic scars, subjects underwent 3 treatment sessions at 1-month intervals consisting of fractional ablative laser treatment, followed by postoperative application of either topical triamcinolone acetonide (20 mg\/mL) or topical 5-fluorouracil (50 mg\/mL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Three sessions of laser-assisted triamcinolone acetonide and 5-fluorouracil delivery both produced reductions in overall scar area. When compared with one another, there were no statistically significant differences in area reduction between the 2 modalities (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .603). However, scars treated with 5-fluorouracil were not associated with side effects seen with corticosteroid therapy, such as dermal atrophy or telangiectasia formation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>As 5-fluorouracil was associated with fewer adverse events, these findings support the use of a nonsteroidal agent in the management of traumatic scars by laser-assisted therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000001678","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T20:15:54Z","timestamp":1540584954000},"page":"423-430","source":"Crossref","is-referenced-by-count":60,"title":["Treatment of Hypertrophic Scars Using Laser-Assisted Corticosteroid Versus Laser-Assisted 5-Fluorouracil Delivery"],"prefix":"10.1097","volume":"45","author":[{"given":"Jill S.","family":"Waibel","sequence":"first","affiliation":[{"name":"Miami Dermatology and Laser Institute, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Wulkan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Rudnick","sequence":"additional","affiliation":[{"name":"Miami Dermatology and Laser Institute, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Daoud","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stony Brook University, Stony Brook, New York; A. Wulkan is currently affiliated with the Laser and Cosmetic Dermatology Center, Lahey Health, Lynnfield, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamadermatol.2013.7761","article-title":"Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report","volume":"150","author":"Anderson","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000637-199402000-00015","article-title":"Improvement of erythematous and hypertrophic scars by the 585 nm pulsed dye laser","volume":"32","author":"Alster","year":"1994","journal-title":"Ann Plast Surg"},{"key":"R3-20230814","first-page":"294","article-title":"Ablative fractional resurfacing for the treatment of a third degree burn","volume":"8","author":"Waibel","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/lsm.20756","article-title":"Fractional nonablative 1540\u2009nm laser resurfacing for thermal burn scars: a randomized controlled trial","volume":"41","author":"Haedersdal","year":"2009","journal-title":"Lasers Surg Med"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/lsm.22038","article-title":"Treatment of burn scars with the 1,550 nm nonablative fractional erbium laser","volume":"44","author":"Waibel","year":"2012","journal-title":"Lasers Surg Med"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.pmrj.2011.07.007","article-title":"Functional improvement after ablative fractional laser treatment of a scar contracture","volume":"3","author":"Kwan","year":"2011","journal-title":"PM R"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lsm.22120","article-title":"Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery","volume":"45","author":"Waibel","year":"2013","journal-title":"Lasers Surg Med"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/lsm.20860","article-title":"Fractional CO(2) laser-assisted drug delivery","volume":"42","author":"Haedersdal","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/dsu.12111","article-title":"Ablative fractional resurfacing in topical drug delivery: an update and outlook","volume":"39","author":"Bloom","year":"2013","journal-title":"Dermatol Surg"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/lsm.22227","article-title":"Laser assisted drug delivery: a review of an evolving technology","volume":"46","author":"Sklar","year":"2014","journal-title":"Lasers Sur Med"},{"issue":"Suppl 12","key":"R11-20230814","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/DSS.0000000000000207","article-title":"Developing technology: ablative fractional lasers enhance topical drug delivery","volume":"40","author":"Erlendsson","year":"2014","journal-title":"Dermatol Surg"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2133.2010.09939.x","article-title":"Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts","volume":"163","author":"Huang","year":"2010","journal-title":"Br J Dermatol"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1524-4725.1999.08165.x","article-title":"Treatment of inflamed hypertrophic scars using intralesional 5-FU","volume":"25","author":"Fitzpatrick","year":"1999","journal-title":"Dermatol Surg"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bjps.2008.03.020","article-title":"The hidden cost of skin scars: quality of life after skin scarring","volume":"61","author":"Brown","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R15-20230814","first-page":"215","volume":"28","author":"Mirastschijski","year":"2015","journal-title":"Ann Burns Fire Disasters"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1524-4725.2011.02137.x","article-title":"Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids","volume":"38","author":"Sadeghinia","year":"2012","journal-title":"Dermatol Surg"},{"key":"R17-20230814","first-page":"1442","article-title":"Comparative results in treatment of keloids with intralesional 5-FU\/Kenalog, 5-FU\/Verapamil, Enalapril Alone, Verapamil Alone, and Laser: a case report and review of the literature","volume":"15","author":"Alexandrescu","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"R18-20230814","first-page":"2772","article-title":"Correlation between dihydropyrimidine dehydrogenase and efficacy and toxicity of fluoropyrimidine drugs","volume":"18","author":"Liu","year":"2014","journal-title":"Eur Rev Medpharmacol Sci"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.burns.2012.09.020","article-title":"Cushing's syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey","volume":"39","author":"Fredman","year":"2013","journal-title":"Burns"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000637-199605000-00013","article-title":"Cushing's syndrome in postburn children following intralesional triamcinolone injection","volume":"36","author":"Ritota","year":"1996","journal-title":"Ann Plast Surg"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40261-016-0484-x","article-title":"A randomized, single-blind trial of clobetasol propionate 0.05% cream under silicone dressing occlusion versus intra-lesional triamcinolone for treatment of keloid","volume":"37","author":"Nor","year":"2017","journal-title":"Clin Drug Investig"},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/SAP.0b013e31827eac5e","article-title":"Prospective, before-after cohort study to assess the efficacy of laser therapy on hypertrophic burn scars","volume":"70","author":"Hultman","year":"2013","journal-title":"Ann Plast Surg"},{"key":"R23-20230814","first-page":"778","article-title":"Intralesional 5-fluorouracil in keloid treatment: a systematic review","volume":"95","author":"Bijlard","year":"2015","journal-title":"Acta Derm Venereol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00042728-201903000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T15:40:01Z","timestamp":1692027601000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201903000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001678","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}